Drug Name:

FULLTERM PP

Therapeutic Use:

Indications for FULLTERM:

Aid in assessing risk of preterm delivery in ≤7 or ≤14 days from the time of cervicovaginal sample collection in women with signs/symptoms of early preterm labor, intact amniotic membranes, and minimal cervical dilation (<3cm), sampled between ≥24 weeks and <35 weeks gestation. Aid in assessing risk of preterm delivery in <35 weeks during routine prenatal visit between 22 weeks and <31 weeks gestation in women with singleton gestation.

ClinicalAdvisor.com is for nurse practitioners and physician assistants, offering the latest information on diagnosing, treating, managing, and preventing medical conditions typically seen in the office-based primary-care setting.

Find all of the news and departments you love from the print issue archived for easy online access, along with special Web-only content.